SPONSOR
Shanghai Tong Ren Hospital
Total Trials
3
Recruiting
3
Phases
Phase 4, Phase 2
Shanghai Tong Ren Hospital is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Pacing Therapy, Cardiac Pacing, Acute Myocardial Infarction, AML, Adult.
The trial portfolio spans Phase 4, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Shanghai Tong Ren Hospital
How many clinical trials has Shanghai Tong Ren Hospital sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Shanghai Tong Ren Hospital, of which 3 are actively recruiting participants. These trials cover conditions including Pacing Therapy, Cardiac Pacing, Acute Myocardial Infarction. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Shanghai Tong Ren Hospital research focus on?
Shanghai Tong Ren Hospital clinical trials span Pacing Therapy, Cardiac Pacing, Acute Myocardial Infarction, AML, Adult. The research pipeline includes Phase 4, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Shanghai Tong Ren Hospital clinical trial?
To participate in a Shanghai Tong Ren Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Shanghai Tong Ren Hospital trials with current recruitment status updated daily.
Clinical Trials by Shanghai Tong Ren Hospital
NCT07603648
Recruiting
Immediate Electrophysiological Effects of Different Atrial Pacing Sites on P-Wave Characteristics
Pacing Therapy
NCT05292404 Phase 4
Recruiting
Impact of Early PCSK9 Inhibitor Treatment on Heart After Acute Myocardium Infarction
Acute Myocardial Infarction
NCT05736965 Phase 2
Recruiting
A Study of Selinexor in Combination With Azacitidine and Venetoclax (SAV Regimen) in Treatment Naïve Participants With Acute Myeloid Leukemia
AML, Adult
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology